Neuronal plasticity associated with learning, memory and development is controlled, in part, by NMDA receptors, which are complexes consisting of the subunit NMDARl (NRl) and one or more NMDARS subunits (NR2A-NR2D).
We made a polyclonal antibody to a C-terminus peptide of NRSA. In analysis of transfected cell membranes, this antibody recognizes NRSA and NRSB, and to a slight extent, NRSC and NRSD. In Western blots of rat brain, the antibody labeled a single band that comigrated with NRSA and NRSB. This antibody (NRSA/ B) did not cross-react with extracts from transfected cells expressing other glutamate receptor subunits, nor did it label non-neuronal tissues. lmmunostained sections of rat brain showed significant staining throughout the nervous system, including olfactory bulb, cerebral cortex, hippocampus, caudate-putamen, and many brainstem nuclei, as well as in neurons of spinal cord and sensory ganglia. This widespread distribution of staining was similar to that found with an antibody to NRl, supporting the presence of functional NRl/ NR2 complexes throughout the nervous system. In the cerebellum, in contrast to staining with NRl antibgdy, Purkinje cell staining with NRSA/B antibody was low, indicating that these neurons may lack functional NMDA receptors. EM examination revealed dense staining in dendrites and postsynaptic densities in cerebral cortex and hippocampus, similar to those seen with antibody to NRl. Since functional NMDA receptor complexes at synapses appear to require both NRl and NR2 subunit proteins for full function, this study provides structural evidence for functional NRl /NR2 receptors in vivo in the nervous system. [Key words: excitatory amino acids, ultrastructure, immunocytochemistry, AMPA, hippocampus, cerebellum] Glutamate receptors are the most widespread neurotransmitter receptors in the CNS, being involved to some extent in nearly every central neural circuit, as well as in many peripheral circuits (e.g., reviewed by Collingridge and Lester, 1989; Monaghan et al., 1989; Nakanishi, 1992) . Glutamate receptors can be divided into four major classes (each containing several subunits), based on both structural and pharmacological properties (reviewed by Nakanishi, 1992; Seeburg, 1993) : (1) metabotropic glutamate receptors (mGluRl-mGluR7; Nakanishi, 1992; Saugstad et al., 1993; Okamoto et al., 1994) ; (2 and 3) two classes of ionotropic, non-NMDA receptors including AMPA (oc-amino-3-hydroxy-5-methyl-4-isoxazolepropionate) receptors (GluR l-GluR4 or GluRA-GluRD) and kainate receptors (GluRS-GluR7, KA 1, KA2); and (4) ionotropic, NMDA receptors. NMDA receptors are perhaps the most widely studied glutamate receptors because of their direct involvement in neuronal development (e.g., reviewed by Burgoyne et al., 1993) and synaptic plasticity, especially involving long-term potentiation and long-term depression (Kirkwood et al., 1993; reviewed by Malenka and Nicoll, 1993) , implicated in learning and memory. NMDA receptors are comprised of two classes of subunits: one subunit of NRl (or NMDARl; Moriyoshi et al., 1991) that exists in at least eight splice variants (Anantharam et al., 1992; Nakanishi et al., 1992; Sugihara et al., 1992; Durand et al, 1993; Hollmann et al., 1993; Kusiak and Norton, 1993; Standaert et al., 1993) ; and four subunits of NR2 (or NMDAR2) , that is, NR2A, NR2B, NR2C, NR2D (NR2D-1, NR2D-2) (Monyer et al., 1992; Nakanishi, 1992; Ishii et al., 1993) . Similar NR subunits have been described in mouse (Ikeda et al., 1992; Kutsuwada et al., 1992; Meguro et al., 1992; Yamazaki et al., 1992) , human (Karp et al., 1993; Planells-Cases et al., 1993) , and Drosophila melunoguster (Ultsch et al., 1993) . Since when expressed alone, these subunits show little (NRl) or no (NR2) physiological response, it is likely that NMDA receptors exist as heteromeric complexes, containing NRl combined with one or more NR2 subunits (Monyer et al., 1992; Nakanishi, 1992; Wafford et al., 1993) ; pharmacology and physiology of the complex would vary according to different combinations of NRl variants and NR2 subunits (Stem et al., 1992; Cik et al., 1993; Durand et al., 1993; Hollmann et al., 1993; Ishii et al., 1993; Mori et al., 1993; Raditsch et al., 1993; Wafford et al., 1993) . In addition to the NRl/NR2 receptor complexes, which seem to correspond most closely to NMDA receptors described in classical physiological studies, a number of other possible NMDA receptors have been reported (Kumar et al., 1991; Itano et al., 1992; Alford and Dubuc, 1993; Mattson et al., 1993; Smimova et al., 1993a,b) .
Data suggesting that NRl/NR2 complexes form the major functional NMDA receptor class in the nervous system come from in situ hybridization (NRl: Moriyoshi et al., 199 1; Shigemoto et al., 1992; Furuyama et al., 1993; Sato et al., 1993; Tiille et al., 1993; Watanabe et al., 1993; NR2: Monyer et al., 1992; Ishii et al., 1993; T611e et al., 1993; Watanabe et al., 1993) and immunocytochemical (NR 1: Brose et al., 1993; Siegel et al., 1994) studies, which show that mRNA (NRl, NR2) and protein (NRl only) for these subunits are widespread throughout the CNS and PNS, consistent with physiological studies identifying functional NMDA receptors in most regions of the nervous system (reviewed by Petralia et al., 1994) .
In this line, immunocytochemical studies have been most useful since they allow confirmation of the presence of the subunit protein within neuronal processes, especially with ultrastructural localization , which can be used, for example, to identify subunits present in specific synaptic populations. In fact, the best morphological evidence for the presence of functional NR l/NR2-type NMDA receptors in the nervous system is the immunocytochemical detection of NR2 because (1) localization of mRNA for an NMDA receptor subunit in a neuron may not always coincide with expression of the protein (Sucher et al., 1993) , and (2) NR2 subunits are required for fully functional NMDA receptors (Monyer et al., 1992; Ishii et al., 1993) ; that is, NRl protein may be present in neurons that neither contain NR2 nor exhibit functional NMDA receptor channels (e.g., Purkinje cells, discussed in . Thus, using an NR2 antibody, we show histological and ultrastructural evidence that NRl and NR2A/B proteins are colocalized in many neuronal populations, and are postsynaptic, supporting their role in NMDA receptor function in viva.
Materials and Methods
Antibody production and characterization. A 20 amino acid peptide, corresponding to the C-terminus of NRZA ( Fig. l) , was conjugated to bovine serum albumin with glutaraldehyde and used to produce antibodies in rabbits, as previously described . The antibodies were affinity purified using the synthetic peptide attached to Activated CH-Sepharose 4B (Pharmacia LKB Biotechnologv, Piscataway, NJ). The specificity of t'he antibodies was determiner&ing immunoblots of rat tissues and transfected cell membranes. The cDNA clones used in this study were kindly provided by the following: NRZA-NR2D, KA 1, and KA2, Dr. P. Seeburg (Univ. Heidelberg); NMDARl, Dr. S. Nakanishi (Kyoto Univ.); GIuR l-GluR7, Dr. S. Heinemann (The Salk Institute). cDNAs were transfected into human embryonic kidney cells (HEK-293) as described . Expression of protein in the transfected cells was verified using antibodies specific for each subunit except for GluRS, KA 1, and NR2D. The amount of transfected cell membrane sample applied to the gel to characterize the NR2A/B antibody was the amount required to produce an intensely stained band using the respective subunit-specific antibody. Samples were prepared and analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) as described . Primary antibody was used at 0.5 pg/ml. Immunoreactive bands were detected using the ECL detection system (Amersham, Arlington Heights, IL). Molecular weights were estimated using unstained standards, myosin (200 kDa), P-galactosidase (116 kDa), phosphorylase B (97 kDa), BSA (66 kDa), and ovalbumin (45 kDa), obtained from Bio-Rad (Richmond. CA). Prestained standards from GIBCO-Bethesda Research Labs were myosin, phosphorylase B, BSA, and ovalbumin and migrated at A4, = 210k, 103k, 7 1 k, and 46k, respectively. For deglycosylation of receptor in transfected cell membranes, SDS-solubilized membranes were treated as described .
Tissue preparation. Young male Sprague-Dawley rats (11 l-2 16 gm) were anesthetized with a 1:l mixture of ketamine and Rompun, and perfused transcardially, as described previously (Petralia and Wenthold, 1992; Petralia et al., 1994) , with 0.12 M phosphate buffer (pH 7.2) followed by 4% paraformaldehyde (in same buffer) with or without 0.1% glutaraldehyde for light/electron or light microscopy, respectively.
Immunocytochemistry. The most useful NR2A/B antibody concentrations were OS-l.5 &ml (for both first and second bleeds), with the most commonly used concentration being 1 &ml. Antibody to NRl was used at 34 &ml for the first bleed (as used in Petralia et al., 1994) and 0.5-l pg/ml for the second bleed. NRl antibodies were run on some sections in most experiments in order to compare results with those obtained with NR2A/B antibody. Only new data on NRl antibody, that is, not included in Petralia et al. (1994) , are mentioned in the results. Also, some sections were immunolabeled with a monoclonal antibody to NRI (provided by Drs. Nils Brose and Stephen F. Heinemann, The Salk Institute; Sucher et al., 1993; Siegel et al., 1994) . We used a preembedding immunocytochemical procedure as described in detail previously (Petralia and Wenthold, 1992; Petralia et al., 1994) . Figure 1 . Amino acid sequence of the C-terminus of NRZA used to produce the antibody, compared to C-termini of NR2B, NR2C, and NR2D-2. Identical amino acids in NR2B, NRZC, and NR2D-2 are shown in white letters on black.
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Briefly, 50 pm sections were blocked in 10% normal goat serum/PBS, incubated overnight in primary antibody and visualized using an avidin-biotin-peroxidase system (Vectastain kit, Vector Laboratories. Bur-' lington, CA) and 3',3-diaminobenzidine tetiahydrochloride (DAB: 10 mg/20 ml PBS + 5 ~1 30% hydrogen peroxide). Sections for electron microscopy were fixed in 1% osmium tetroxide and embedded in Poly/ BED 8 12 resin (Polysciences, Inc., Warrington, PA). Yellow sections (averaging 75 nm) were taken from the edge (i.e., perpendicular to the plane of the section) of the 50 urn sections on an LKB Ultratome IV &ramicrotome, anh examined' unstained in a JEOL JEM-100CX II transmission electron microscope.
Controls. Sections in which PBS was substituted for the primary antibody (PBS controls) were run in every experiment for both light and electron microscopy of all structures studied. In addition, three preadsorption control tests were run in which sections were incubated with antibody that was preincubated with specific peptide conjugated to BSA (50 &ml), along with appropriate accompanying sections treated with primary antibody (without peptide) and sections with primary antibody and glutaraldehvde-treated BSA (50 Ml/ml. without DeDtidek Anatomical &vey. Basic pro&d&es w&e as de&&ed in previous studies (Petralia and Wenthold, 1992; Petralia et al., 1994) . Sagittal sections (17 sides of 13 rats) were taken from up to six levels (PW79-85; i.e., corresponding to Figures 79-85 in Paxinos and Watson, 1986) . Coronal sections (four rats) were taken from up to 13 different levels, corresponding to figures in PW. Transverse sections from cervical spinal cord (14 rats), cervical dorsal root ganglia (14 rats), trigeminal ganglia (2 rats), pituitary glands (15 rats), and pineal glands (12 rats) were examined. In addition, sections were examined from one female rat (134 gm) and included sagittal sections (one side), cervical spinal cord, pineal gland, and cervical dorsal root ganglia. Thin sections for electron microscopy (two rats) of cerebral cortex, hippocampus and cerebellum were taken from sagittal vibratome sections corresponding to PW82-85 as described for the NRl study . All layers of cerebral cortex and cerebellar cortex and CAl/CA2 and CA3 regions of hippocampus were examined with electron microscopy. However, layers of the cerebral cortex were not identified in thin sections.
As described previously (Petralia and Wenthold, 1992; Petralia et al., 1994) , choice of optimum antibody concentrations was based on the presence ofdense staining in some structures as compared to PBS control sections. Level ofstaining in Table 1 represents the average ofall animals examined, and was based on an arbitrary relative scale where the densest stained structures were assigned a value of 4, and structures in which staining was not higher than the PBS control were assigned a value of 0. Designations of staining intensity in the text of "light, moderate, moderately dense, and dense" correspond roughly to table values of 1, 2, 3, and 4, respectively. Density of staining was compared among structures stained with each antibody (NR 1, NR2A/B) but not between the two antibodies. Typically, staining penetrated several micrometers on both sides of the section; lack of staining in the middle of the width of the section was considered in all assessments of light and electron microscope localization of staining. Staining is described as "neuropilar" and "neuronal." as defined in Petralia and Wenthold (1992: see also Petralia et al., i994) ; that is, neuronal staining refers to staining of the cell body, excluding nucleus, and the major dendrites that could be traced from the cell body, while neuropilar staining includes processes not traced to specific cell bodies and the unresolvable matrix between cells. Our descriptions of immunostaining in large structures of the brain (e.g., amygdala, hypothalamus, septum, thalamus, etc.) can be considered valid for the portion examined only, since such structures extend beyond the sections examined as described above, and as noted previously (Petralia and Wenthold, 1992) . Identification of structures with electron microscopy was based on defined criteria (e.g., Peters et al., 1991) , as reviewed previously (Petralia and Wenthold, 1992; Petralia et al., 1994) . Basomedial n./posterodorsal medial n./lateral n. Central n. Dorsal endopiriform n. Lateral septal n., pars dorsalis Basal ganglia Caudate-putametinucleus accumbens Globus pallidus/subthalamic n./basal n. Meynert 2-2.5 2-2.5 2-2.5 2.5 0.5-l 2-2.5 1.5-2 2 2-2.5 3-3.5 2.5-3 2.5-3 l-l.5 2.5-3.5
2.5-3 1.5-2 2-2.5
1.5-2 2.5-3 1.5 2.5-3.5 1.5 1-2 2 2.5-3.5 2-2.5
1.5-2 2-3 2 1.5-2 2.5-3.5 2 1.5-2 l-l.5 2-3 2 2.5-3.5 2.5-3 2-3 2-2.5 2.5 2 2-2.5 2-3 2 Gigantocellular n./paragigantocellular n. Large neurons Lateral n. Pontine n., caudal part 2-3 2-2.5 2.5 2.5-3 2-2.5 2 2 2.5-3 2.5 2.5 2.5-3 1.5-2 2 2.5-3 2-2.5 1.5-2 2-2.5 2.5 1.5-2 2.5-3.5 2-2.5 2 2.5-3 2-2.5 1.5-2 2 2.5-3.5 2-2.5 3-3.5 2.5 2.5-3 2.5-4 2 3 1.5 2.5-3 1.5-2 1.5-2 3-4 2.5-3 1.5-2 Oral part, large neurons 34 Localization is scaled from 0 to 4, where 0 represents the level seen in corresponding control sections and 4 is the densest staining. -, staining not evident.
Results
Immunoblot analysis of membranes of HEK-293 cells transfected with NR2A showed a single immunoreactive band migrating at IV, estimated to be 172,000 (Fig. 2~ ). NR2B showed two immunoreactive bands, one comigrating with NR2A and the second estimated to migrate at an M, of 165,000. Immunolabeling of both NR2A and NR2B was blocked by previous treatment of the antibody with the synthetic peptide used to produce the antibody (Fig. 2b) . The two immunoreactive bands in the NR2B sample appeared to represent the glycosylated and deglycosylated forms of the protein, since enzymatic deglycosylation with N-glycosidase F resulted in labeling only at the lower molecular weight (Fig. 2~ ). This treatment also reduced the size of NR2A to an M, of 165,000. In addition to the robust recognition of NR2A and NR2B, we saw a minor recognition of NR2C and NR2D-2 (Fig. 2~) . The identification of NR2B and NR2C was verified using antibodies selective for NR2B and NR2C, respectively (R. Wenthold, unpublished observation), while the position of NR2D-2 was estimated based on its molecular weight. No interaction was seen with NRl ( Fig. 2~) or subunits of non-NMDA receptors (Fig. 2d) . Analysis of immunoblots of rat tissues showed labeling of a single band migrating with a IV, estimated to be 172,000 (Fig. 3) . Labeling was most intense in cortex and hippocampus and light in hindbrain and cerebellum. Staining corresponding to the molecular weight of the NR2C subunit was not seen in cerebellum, even with heavily developed immunoblots. Staining was not seen in nonneuronal samples.
Light microscope distribution
Immunostaining with antibody to NR2A/B was widespread throughout the nervous system (Figs. 4-9) , and the overall distribution in neuronal populations resembled that described for antibody to NRl (Figs. 4, 6, 8 ) . Many regions contained substantial staining with antibody to NR2A/B in the neuropil, with moderately dense staining in dendrites and puncta, and less staining in neuron cell bodies (Figs. 6, 8 ). In contrast, staining of the same structures with antibody to NR 1 often was substantial in neuron somas and only light to moderate in neuropil (Figs. 6c, 8d) .
The best examples of prominent neuropilar staining with NR2AIB antibody were the external plexiform layer of the olfactory bulb (Figs. 4b, 6~ ) and the cerebral cortex (Fig. 6b,d ). In the former, most mitral cell bodies and neuron cell bodies of the external plexiform layer were stained lightly with antibody to NR2A/B, while dendritic processes of all sizes were stained moderately to densely. In the cerebral cortex, pyramidal cell bodies (layers 3 and 5) were stained lightly to moderately while their major apical dendrites were stained moderately to densely. Staining in other neuron somas and dendrites of the cerebral cortex was variable and generally moderate. In comparison, densest staining seen with antibody to NRl was in the mitral (Fig. 4~) and pyramidal (Fig. 6c) cell bodies of olfactory bulb AOB, accessory olfactory bulb; Ar, arcuate hypothalamic n.; BI, basolateral amygdaloid n.; cc, corpus callosum; CP, caudate-putamen; DC, dorsal cochlear n.; DG, dentate gyrus; DH, outer dorsal horn; EC, external cuneate n.; EP, external plexiform layer of olfactory bulb; Fr, frontal cortex; Ha, habenula; HI, hindlimb area of cortex; IC, inferior colliculus; IO, inferior olive; In, interposed cerehellar n.; La, lateral amygdaloid n.; LD, lateral septal n., dorsal part; Me, median eminence; Mi, mitral cell layer of olfactory bulb, Mn, motoneurons of ventral horn; ox, optic chiasm; Pi, pirifonn cortex; Pn, pontine n.; PI, parietal cortex, area 1; Rt, reticulothalamic n.; SC, superior colliculus; SC, suprachiasmatic n.; So, supraoptic n.; SK, spinal trigeminal n., caudal part; Tu, olfactory tubercle; VC, ventral cochlear n.; 7, facial n.; 8, auditory nerve; 12, hypoglossal n.; III, third ventricle: IV. fourth ventricle. In all light microscope figures (Q-9) dorsal is to the top and rostra1 is to the left (sagittal sections) unless otherwise stated. Magnification: a and b, 3.6 x ; c and d, 7.1 x. paraventricular nuclei as described for antibody to NRI , although staining reached only moderately dense levels with NR2A/B antibody compared to dense levels with NRl antibody. Both neurons and neuropil of the suprachiasmatic nucleus (Fig. 5~) were stained lightly to sometimes moderately with antibody to NR2A/B, while they were stained moderately with antibody to NRl . In the arcuate nucleus/median eminence region (Figs. 4d, 8g,h ), sections immunolabeled with antibody to NR2A/B bore numerous dense puncta in the external layer of the median eminence. Smaller puncta were dot-like while larger ones often were shaped like irregular rings.
These puncta often were arranged in long trains, presumably reflecting their regular placement along an unstained process, which was sometimes visible. Such puncta were uncommon and less definitive in the internal layer of the median eminence and arcuate nucleus. In contrast, with antibody to NRl, similar puncta were common in the internal layer of the median eminence and arcuate nucleus, and were rare in the external layer of the median eminence (origin of the pituitary portal system; for example, Armstrong, 1985) (Fig. 8~) . Staining was prominent in all lobes of the pituitary with both antibodies, although it was densest in the anterior and posterior lobes with antibody to NR2A/B and in the intermediate lobe with antibody to NR 1 .
Immunostaining was prominent and similar overall with both antibodies throughout many nuclei in the midbrain and hindbrain (Table 1, Fig. 9a,b) , including the dorsal cochlear (Fig.  5b) , lateral vestibular (Fig. 9a) , trigeminal motor (Fig. 9b) , facial, supraspinal nuclei, large multipolar neurons of the deep layers of the superior colliculus, a few large multipolar neurons in the external cortex of the inferior colliculus, and large neurons of some medial reticular nuclei such as the gigantocellular and paragigantocellular nuclei. Staining of neurons in some nuclei, such as the dorsal motor nucleus of the vagus, hypoglossal nucleus, inferior olive, and locus coeruleus, typically was light with NR2A/B antibody compared to a moderate or moderately dense staining with NRl antibody ; although neuropilar staining was moderate with both antibodies. Staining with antibody to NR2A/B of the cortex of the cerebellum was moderate overall, in both granular and molecular layers (Figs. 4b, 5b, SC). Purkinje cell staining with NR2A/B antibody varied from unstained to lightly stained (Figs. 4b, 5b, SC), in contrast to staining with antibody to NRl in which the Purkinje cell bodies were stained densely ( Fig. 4a) . Staining with antibody to NR2A/B was prominent in the pinceau (Fig. SC) , that is, a complex structure consisting mainly of a branched, convoluted basket cell axon surrounding the proximal portion of the Purkinje cell axon (Palay and Chan-Palay, 1974) . Staining of this structure was not evident with antibody to NR 1. Staining in the cervical spinal cord was most prominent in lamina IX and dorsal horn. In lamina IX, many large motoneurons were stained moderately dense to densely, and the moderately stained neuropil contained numerous, large, dense puncta (Fig. 9d) . Neurons in most other laminae (V-VIII) were stained lightly or were unstained. In contrast, many neurons in these lamina stained moderately with antibody to NRl . In cranial (vestibular, trigeminal) and spinal ganglia, neurons of all sizes stained moderately to densely with antibodies to NRl and NR2A/B. No definitive differences in staining pattern were seen between sections from male rats and a limited number of sections from a female rat, although it is likely that some differences in NMDA receptors exist between sexes (Akinci and Johnston, 1993; Hanack and Loscher, 1993) .
Electron microscope distribution
Immunostaining with antibody to NR2A/B was dense in many dendrites throughout the cerebral cortex, hippocampus, and cerebellar cortex. Staining was less dense in cell bodies and other dendrites and consisted of patches of staining. These patches were associated with microtubules, vesicles, rough endoplasmic reticulum, Golgi, and the surfaces of mitochondria and the nuclear envelope, as described for immunolabeling with antibody to NR 1 . Immunostaining of synapses usually was limited to the postsynaptic density and membrane and associated cytoplasm, with no staining in the synaptic cleft and little or none in the presynaptic terminal, which contained round or pleomorphic (mostly round) vesicles. Absence of staining in the cleft supports an intracellular location of the C-terminus of NR2, as suggested for NRl (Tingley et al., 1993; Petralia et al., 1994) . Although staining was usually only postsynaptic, a light staining was found rarely in presynaptic terminals but was not definitive. In spine synapses, staining typically extended throughout the entire spine head and into the neck, and sometimes was very dense. There was no clear evidence of staining in glia although some of the small, stained, unidentified processes could be parts of glial cells. Other stained structures included the inner surface of blood vessels and, occasionally, myelinated axons (as noted for CA 1 -hippocampal myelinated axons with antibodies to AMPA receptors; Martin et al., 1993) .
In the cerebral cortex (Fig. lo) , stained dendrites and synapses were found throughout the gray matter with antibody to NR2A/ B. Among postsynaptic densities with definitive staining, dense staining (Fig. lOb,c) was seen more commonly with NR2A/B antibody than with NRl antibody . One example of dense immunolabeling of a presynaptic terminal was seen, but structural details were obscured by the staining.
In the hippocampus (Fig. 1 I) , densely stained postsynaptic densities and spines were found commonly in stratum oriens (Fig. 1 la,b ) and molecular layer (Fig. 1 lc,d ) of both the CAY2 and CA3 regions. In the stratum lucidum, staining sometimes was seen in postsynaptic densities of specialized spines of mossy fiber synapses (Fig. 11 e) . While this staining was not common, it varied from light to dense, compared to the light staining seen uncommonly in similar synapses with antibody to NRl . In addition, patches of staining were found in (Fig. 1 lg) , which were found in bundles, that is, presumptive mossy fibers as described in Petralia et al. (1994; see also Siegel et al., 1994) . Definitive staining was not found in presynaptic mossy fiber terminals, although patches of staining were seen sometimes.
In the cerebellar cortex (Fig. 12) patches of immunostaining were found in some Purkinje cell bodies and dendrites. Postsynaptic staining in presumptive Purkinje cell spines (i.e., longnecked spine with postsynaptic density on side of head) apposed by parallel fibers (Mugnaini, 1972; Palay and Chart-Palay, 1974) was definitive but not common. Other occasional stained postsynaptic densities were on short, wide spines or on main dendritic shafts, probably from small neurons. In the granular layer, a few patches of staining were found in the cytoplasm of granule cell somas (Fig. 12~ ) and in dendritic processes in glomeruli. While some of the latter staining extended to the adjacent cell membrane apposed to the presynaptic mossy terminal, definitive staining of postsynaptic membranes and densities in glomeruli was not apparent. Typically, mossy fiber terminals in the glomeruli were not stained although portions of the terminal sometimes were stained lightly. Dense staining was found in cytoplasm and cell membrane of many processes of the pinceau Figure 10 . Electron micrographs of cerebral cortex. Immunostaining with antibody to NR2A/B is shown in b and c. a, Control section (no primary antibody) shows complete absence of immunostaining in synapse (un; this example was one of the densest found; most were lighter). Note moderate staining in myelin (asterisks). b and c, Dense staining was found in dendrites (d) and in postsynaptic densities (arrows) and adjacent cytoplasm of dendritic spines. un, unstained synapse. Magnification, 50,000 x . (Fig. 12~ ). In addition, staining was found in patches in unmyelinated fibers found in bundles in the molecular layer (Fig.  12b) , that is, presumed parallel fibers, as described for staining with antibody to NRl .
Controls
Staining was absent from PBS control sections. Preadsorption control sections were unstained except for a very light staining in some cells and processes, notably the trigeminal sensory, lateral reticular, pontine, supraoptic, and dorsal cochlear nuclei, and sometimes Purkinje cells. In addition, staining in the pineal gland, posterior pituitary lobe and glia of the peripheral white matter of the spinal cord was only slightly reduced by preadsorption. Corresponding experimental sections (i.e., no peptide) were stained normally. Staining was absent from PBS control thin sections of cerebral cortex, hippocampus, and cerebellar cortex examined with electron microscopy (Figs. lOa, 1 lfl, except for myelin sheaths of axons (Fig. lOa) and large, multivesicular body-like structures, as described for NRl . As in the NRl study, synapses were never stained except for a few of the small spine synapses, which bore lightly stained postsynaptic densities, in the stratum oriens and molecular layer of the hippocampus. None of the latter possessed dense staining as seen with NR2A/B antibody in postsynaptic densities and cytoplasm of small spine synapses of these regions. 
Discussion
In this study we developed an antibody to the C-terminus of NR2A that reacts intensely with both NR2A and NR2B on immunoblots of transfected cell membranes and labels a single band that comigrates with the NR2A and NR2B subunits in rat brain tissues. Since four and six of the 20 amino acid residues of the sequence used for producing the antibody are identical in NR2C and NR2D-2, respectively, we performed immunoblot analysis of membranes of cell transfected with these subunits, and found a weak reaction with both NR2C and NR2D-2. Corresponding labeling of bands in rat tissues, particularly cerebellum where NR2C is most abundant and in hindbrain where NR2D is most abundant, was not seen. This lack of labeling is likely due to the low affinity of the antibody for the NR2C and NR2D-2 subunits or may indicate a relatively low expression of these subunits in brain. Based on these results we interpret our immunocytochemical labeling to represent primarily the NR2A and NR2B subunits. This is supported by the fact that the antibody gives rather weak labeling in the cerebellum, where NR2C is most abundantly expressed. However, we cannot rule out the possibility that in some populations of neurons, NR2C and NR2D-2 are abundantly expressed, and our labeling reflects primarily these subunits. The similarity of this distribution to that of antibody to NRl indicates that NRl and NR2 colocalize in most neurons in the CNS, as indicated in in situ hybridization studies (Monyer et al., 1992; Nakanishi, 1992; Ishii et al., 1993) . This is consistent with physiological studies that support the presence of functional NMDA receptors in most structures in the CNS (discussed in Stone and Burton, 1988; Collingridge and Lester, 1989; Petralia et al., 1994) . Ultrastructural distribution of NR2 was also similar to that of NRl, with staining most commonly found in dendrites and postsynaptic membranes and densities. Any differences in staining density in individual structures examined with light or electron microscopy may reflect differences in distribution and/or different ratios of NR 1 :NR2 subunits in various portions of individual neurons. The widespread distribution of NRl and NR2A/B antibody staining in neuronal populations implies colocalization with other glutamate receptor types throughout the nervous system (see discussion in Petralia et al., 1994) ; this supports a model in which postsynaptic membranes contain non-NMDA receptors for fast excitatory transmission and NMDA receptors that modify the response (Bekkers and Stevens, 1989; Jones and Baughman, 199 1; Riquelme et al., 1993) .
Comparison to in situ hybridization and ligand binding studies
The pattern of immunostaining with antibody to NR2A/B corresponds to the combined patterns of mRNA distribution of NR2A and NR2B, with a possible contribution of NR2C and NR2D (Monyer et al., 1992; Nakanishi, 1992; Watanabe et al., 1992 Watanabe et al., , 1993 Ishii et al., 1993) . For example, substantial staining in some neuron populations of midbrain and hindbrain corresponds to significant mRNA levels of NR2A, such as in the pontine nuclei, inferior colliculus, and inferior olive (Ishii et al., 1993) . Staining in some structures such as hypothalamus and spinal cord, where little or no mRNA for NR2A and NR2B has been detected, could reflect the presence of NR2C or NR2D et al. -NMDA Receptor Distribution i n Rat Brain (Monyer et al., 1992; Ishii et al., 1993; Tijlle et al., 1993; Watanabe et al., 1993) . The lower staining with NR2A/B antibody than with NR 1 antibody in many neuron types throughout many regions of the brain may correspond to the apparent high expression of mRNA for NR 1 compared overall to NR2A-NR2D, as illustrated for many forebrain structures (Monyer et al., 1992; Nakanishi, 1992) possibly indicating (1) the expression of NMDA receptor complexes with high NRl:NR2 ratios, (2) additional expression of monomeric NRl receptor complexes, and/ or (3) a higher cytoplasmic pool of NR 1. However, lower staining seen in some structures that contain a predominance of NR2D mRNA (i.e., throughout the brain stem; Ishii et al., 1993) may be due to low detection of NR2D protein by our antibody, as indicated on immunoblots, or to a predominance of mRNA for NR2D-1, which is not detected by our antibody. Petralia et al., 1994) . The low levels of NR2 protein sometimes seen in Purkinje cells in our study may be nonspecific since similar levels sometimes were seen in preadsorption controls. However, cell level studies of NR2 mRNA distribution in the cerebellum have not been published, and we cannot rule out that one or more NR2 subunits are present in low amounts in some Purkinje cells. As with the antibody to NR 1, the widespread distribution of NR2A/B antibody is consistent overall with data from NMDA ligand binding studies, and has been discussed in detail for NR 1 antibody . As also noted in that article (see also Monaghan et al., 1993) and demonstrated by pharmacological/binding studies of subunit expression in cell cultures and oocytes (Buller et al., 1993; Marti et al., 1993; Raditsch et al., 1993; Wafford et al., 1993; Yamakura et al., 1993) presence of NMDA receptor complexes made up of NRl in combination with one or more NR2 subunits may account for many of the differences in ligand binding seen in different regions of the brain. Interestingly, higher dendritic staining with NR2A/B antibody, compared to higher cell body staining with our NRl antibody, corresponds with higher binding of NMDA-sensitive @H-glutamate in dendritic zones compared to white matter regions and cell body layers (Monaghan and Cotman, 1985) that is, suggesting a direct relationship between NR2 subunit and ligand-binding site distribution.
Cellular distribution
The dense staining seen with our NRl and NR2A/B antibodies in many neuron cell bodies could indicate maintenance of a high cytoplasmic pool, as suggested for AMPA receptors (e.g., Petralia and Wenthold, 1992) . Immunostaining with antibodies to NRl and NR2A/B, in many dendrites, dendritic spines, and postsynaptic densities implies that complexes of NR l/NR2 subunits are present postsynaptic to glutamatergic input. In the cerebral cortex, densely stained postsynaptic densities were less common with NRl antibody than with NR2A/B antibody, perhaps reflecting a typically lower number of NR 1 subunit molecules in the postsynaptic region. This could be due to variations in NR 1 :NR2A/B ratios in receptor complexes. Alternatively, moderate staining with NR 1 antibody could reflect its detection of only four of the NRl variants, although these four are the major ones expressed in rat brain (Sugihara et al., 1992) . In the hippocampus, the intense postsynaptic labeling of many small spine synapses with NR2A/B antibody complements the widespread distribution of staining for NRl in similar synapses, thus supporting numerous studies showing NMDA receptor-mediated long term potentiation (LTP) in both CA 1 and CA3 regions (discussed in Zalutsky and Nicoll, 1990; Malenka and Nicoll, 1993; Petralia et al., 1994) . In postsynaptic densities apposed by mossy fiber terminals in the CA3 region of the hippocampus, immunostaining was typically low with either NR 1 or NR2A/B antibodies, although dense staining with antibody to NR2A/B was seen in a few active zones. This is generally consistent with the presence of only NMDA-independent LTP in this synaptic population (e.g., Zalutsky and Nicoll, 1990) although the data suggest the presence of limited populations of NR 1 and NR2 subunits. Differential staining of outer and inner portions of the dentate gyrus molecular layer implies that different levels ofNR2 subunits are associated with different inputs onto granule cell dendrites (see discussion for NRl; Petralia et al., 1994) . The pattern of staining with NR2 antibody, that is, denser staining in the outer portion, differs from that described in some studies with NR 1 antibodies (polyclonal NR 1: Petralia et al., 1994; monoclonal NRl: Siegel et al., 1994 ; R. S. Petralia, Y.-X. Wang, and R. J. Wenthold, unpublished observations), but resembles that described in another (polyclonal NRI: Brose et al., 1993) . Differences between the staining with our NR2 antibody and that of NR 1 antibodies can be attributed to the presence of different ratios of NRl:NR2 associated with different inputs. The similarity of our NR2 antibody staining to that of one of the polyclonal NRl antibodies (Brose et al., 1993) may be due to preferential recognition of different subunit variants by different antibodies. In sections of cerebellar cortex immunostained with antibody to NR2A/B, the infrequency of stained, postsynaptic densities in presumptive Purkinje cell spines apposed to parallel fibers is consistent with the typically low staining of Purkinje cells. The few examples of stained densities may represent a minor subpopulation of Purkinje cell spines containing NR2 subunits. The significant staining for NR 1 and NR2A/B of presumptive parallel fibers in the molecular layer may account for at least part of the high levels of NR 1 and NR2 mRNA found in the granular layer (Moriyoshi et al., 1991; Monyer et al., 1992; Ishii et al., 1993; Watanabe et al., 1993) , that is, NR2 protein expressed in the axons of the granule cells. Nevertheless, there is considerable evidence for NMDA receptors at granule cell-mossy fiber synapses (e.g., Silver et al., 1992) , although staining of these synapses with NRl and NR2A/B antibodies was not definitive. This low staining may be due, at least partly, to the low detection of NR2C by NR2A/B antibody, since NR2C mRNA is high in the granular layer (Ishii et al., 1993) . Staining with NR2A/B antibody of the pinceau may be due to cross-reaction with another antigen, that is, a protein that is highly localized to the pinceau (Tigyi et al., 1990) , or indicate that molecular layer basket cells contain NR2. Presence of NR2 mRNA in molecular layer cells has not been described, substantial mRNA has been described only in the granular layer (Ishii et al., 1993; Watanabe et al., 1993) . A preliminary report describes immunostaining of molecular layer cells with an NR2C antibody (Mulac-Jericevic et al., 1993) but these results have not been corroborated.
